سعر فلازاكور 6مجم 10 اقراص 2025

Deflazacort 6 mg tablets (Sedico), pack of 10 tablets.

• Treatment of Duchenne muscular dystrophy (DMD) in patients 2 years of age and older (US-approved indication).Population: Patients 2 years and olderDailyMed (U.S. NLM)

• Most common (>=10% and more than placebo in DMD trials): Cushingoid appearance, weight increase, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity and nasopharyngitis.International label, same formulation · DailyMed (U.S. NLM)

• Known hypersensitivity to deflazacort or to any of the inactive ingredients.International label, same formulation · DailyMed (U.S. NLM)

• Alterations in endocrine function: monitor for Cushing syndrome, hyperglycaemia and adrenal insufficiency after withdrawal.International label, same formulation · DailyMed (U.S. NLM)
• Immunosuppression and increased risk of infection, including reactivation of latent infections; signs of infection may be masked.International label, same formulation · DailyMed (U.S. NLM)
• Can raise blood pressure, cause salt and water retention and increase potassium and calcium excretion; use with caution in heart failure, hypertension or renal insufficiency.International label, same formulation · DailyMed (U.S. NLM)

• Moderate or strong CYP3A4 inhibitorsGive one third of the recommended dosage.DailyMed (U.S. NLM)
• Moderate or strong CYP3A4 inducersAvoid concomitant use.DailyMed (U.S. NLM)

• Corticosteroids should be used in pregnancy only if the potential benefit justifies the potential risk; infants of mothers given substantial doses should be observed for hypoadrenalism.International label, same formulation · DailyMed (U.S. NLM)
• Systemic corticosteroids appear in human milk and could suppress growth or interfere with endogenous corticosteroid production; weigh benefits of breastfeeding against maternal need.International label, same formulation · DailyMed (U.S. NLM)

• Deflazacort: Prodrug; its active metabolite 21-desDFZ acts through the glucocorticoid receptor to exert anti-inflammatory and immunosuppressive effects (US Emflaza label).